Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues
Operating expenses:
Research and development	1,506,308	2,654,772
General and administrative	1,744,918	1,358,679
Total operating expenses	3,251,226	4,013,451
Operating loss	(3,251,226)	(4,013,451)
Other income (expense):
Interest income		3,173
Interest expense	(1,824)	(14,560)
Amortization of debt discount and offering costs	(8,723)	(13,506)
Total other expense	(10,547)	(24,893)
Net loss	$ (3,261,773)	$ (4,038,344)
Basic and diluted net loss per share (in Dollars per share)	$ (0.04)	$ (0.07)
Weighted average common shares outstanding - basic and diluted (in Shares)	86,726,347	61,560,279